CE-224535

Generic Name: CE-224535

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₂₉ClN_₄O_₆

CAS Number: 724424-43-5

Unique Ingredient Identifier: T8B02RAU3C

Background: CE-224535 has been used in trials studying the treatment of Osteoarthritis.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) Pain

Phase 2

Terminated

Conditions: Osteoarthritis

Interventions: Drug: naproxen
Drug: placebo
Drug: CE-224535

First Posted Date: 2007-01-05

Last Posted Date: 2018-12-05

Lead Sponsor: Pfizer

Target Recruit Count: 212

Registration Number: NCT00418782

Locations: 🇺🇸
Pfizer Investigational Site, Spokane, Washington, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy